Engrail Therapeutics is a company that develops medicines to transform the lives of patients with life-limiting diseases of the nervous system. The company combines biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Its flexible transaction model includes licensing, co-development, and company acquisitions.